Literature DB >> 10991948

Ubiquitin-mediated proteolysis of a short-lived regulatory protein depends on its cellular localization.

U Lenk1, T Sommer.   

Abstract

In this study we demonstrate that the Deg1 degradation signal of the transcriptional repressor Matalpha2 confers compartment-specific turnover to a reporter protein. Rapid degradation of a Deg1-containing fusion protein is observed only when the reporter is efficiently imported into the nucleus. In contrast, a reporter that is constantly exported from the nucleus exhibits an extended half-life. Furthermore, nuclear import functions are crucial for both Deg1-induced degradation as well as for the turnover of the endogenous Matalpha2 protein. The conjugation of ubiquitin to a Deg1-containing reporter protein is abrogated in mutants affected in nuclear import. Obviously, the Deg1 signal initiates rapid proteolysis within the nucleoplasm, whereas in the cytosol it mediates turnover via a slower pathway. In both pathways the ubiquitin-conjugating enzymes Ubc6p/Ubc7p play a pivotal role. These observations imply that both the cellular targeting of a substrate and the compartment-specific activity of components of the ubiquitin-proteasome system define the half-life of naturally short-lived proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991948     DOI: 10.1074/jbc.M006949200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Rapid degradation of auxin/indoleacetic acid proteins requires conserved amino acids of domain II and is proteasome dependent.

Authors:  J A Ramos; N Zenser; O Leyser; J Callis
Journal:  Plant Cell       Date:  2001-10       Impact factor: 11.277

Review 2.  Degradation or maintenance: actions of the ubiquitin system on eukaryotic chromatin.

Authors:  Helle D Ulrich
Journal:  Eukaryot Cell       Date:  2002-02

3.  A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation.

Authors:  Balasubrahmanyam Medicherla; Zlatka Kostova; Antje Schaefer; Dieter H Wolf
Journal:  EMBO Rep       Date:  2004-05-28       Impact factor: 8.807

4.  The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.

Authors:  Madhurima Biswas; Diane Phan; Momoko Watanabe; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

5.  Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways.

Authors:  Tommer Ravid; Stefan G Kreft; Mark Hochstrasser
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

6.  Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machinery.

Authors:  Meredith Boyle Metzger; Matthew J Maurer; Beverley M Dancy; Susan Michaelis
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

7.  TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination.

Authors:  Chuan-Jin Wu; Dietrich B Conze; Xiaoming Li; Sai-Xia Ying; John A Hanover; Jonathan D Ashwell
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

8.  Yeast importin-α (Srp1) performs distinct roles in the import of nuclear proteins and in targeting proteasomes to the nucleus.

Authors:  Li Chen; Kiran Madura
Journal:  J Biol Chem       Date:  2014-10-01       Impact factor: 5.157

9.  Phosphorylation of clock protein PER1 regulates its circadian degradation in normal human fibroblasts.

Authors:  Koyomi Miyazaki; Takahiro Nagase; Miho Mesaki; Junko Narukawa; Osamu Ohara; Norio Ishida
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

10.  Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPARγ for proteasomal degradation.

Authors:  Hao Dou; Yuyao Duan; Xiaohui Zhang; Qian Yu; Qian Di; Yu Song; Peishan Li; Yaoqin Gong
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.